Ironwood Pharmaceuticals | IRWD - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Akebia Therapeutics USD 173.88M 10.95M 2026-03
Almirall EUR 350.64M 52.12M 2025-12
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
Amarin USD 179.64M 14.82M 2026-03
Ardelyx USD 109.57M 20.96M 2026-03
Astellas Pharma JPY 1.22T 106.19B 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
Charles River Laboratories USD 1.09B 26.61M 2026-03
Coherus Biosciences USD 140.39M 231.91M 2025-12
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Esperion Therapeutics USD 300.36M 451K 2026-03
Halozyme Therapeutics USD 363.21M 186.12M 2026-03
Incyte USD 1.49B 25.52M 2026-03
Ironwood Pharmaceuticals USD 236.31M 5.91M 2026-03
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
MacroGenics USD 95.94M 52.82M 2026-03
Moderna USD 2.4B 408M 2026-03
Myriad Genetics USD 130.2M 3.6M 2026-03
Pacira USD 108.79M 11.8M 2026-03
PTC Therapeutics USD 923.6M 44.82M 2026-03
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
Takeda JPY 2.43T 180.65B 2026-03
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12